Australian Operations
Include All CSL Sites

Box Jellyfish Antivenom

Box Jellyfish Antivenom

Products of National Significance to Australia
Box Jellyfish Antivenom is used to treat systemic envenomation or patients with extensive local involvement causing extreme pain non-responsive to routine analgesia. It is administered by a suitably qualified health professional.
Box Jellyfish
Who is this information for?
This information is relevant in Australia and is intended for people who have been prescribed this product or health care professionals.

Consumer Medicine Information
The Consumer Medicine Information (CMI) is a leaflet written for consumers. The CMI contains information about the medicine including:
  • What this product is used for
  • When this product is used
  • Who should not have this product
  • Before you have this product
  • Side effects
  • The dose of this product
  • What this product contains
  • How to store this product
Box Jellyfish Antivenom CMI (PDF, 35KB)

Product Information
Product Information contains information to ensure the safe and effective use of a medicine. This document is approved by the Therapeutic Goods Administration and made available by bioCSL for you if you are a:
  1. qualified healthcare professional; or
  2. consumer, provided you have read the Consumer Medicine Information for the product; want further information on the product; and agree to consult with your healthcare professional if you have any questions in relation to the Product Information.
Box Jellyfish Antivenom Product Information (PDF, 0.04MB)

Illustration copyright Dr Julian White.

Last Updated: 28-08-2019
LinkedIn Twitter Facebook Google+
© 2019 Seqirus